Are Ellenberg indicator values useful to predict the risk of nitrate leaching in forests?

Die Definition der N-Sättigung von Wäldern wurde bisher überwiegend an N-Haushaltsgrößen geknüpft (ÅGREN & BOSATTA 1988, ABER et al. 1989, KÖLLING 1991, BML 2000). Aber auch mit vegetationskundlichen Methoden ist es möglich, Veränderungen des N-Status zu erkennen (ROST-SIEBERT & JAHN 1988, DIEKMANN & DUPRE 1997, BRUNET et al. 1998, DIEKMANN et al. 1999, FISCHER 1999, LAMEIRE et al. 2000, HOFMEISTER et al. 2002, BERNHARDT 2005). Dies geschieht oftmals mit Hilfe der Stickstoff- und Reaktions-Zeigerwerte nach Ellenberg (ELLENBERG et al. 2001). Sie können damit zur Indikation des Standortzustands von Wäldern und seiner Änderungen herangezogen werden. Im vorliegenden Aufsatz wurde untersucht, welchen Beitrag die Zeigerwerte der Bodenvegetation zur Vorhersage erhöhter Nitratkonzentration unter Wäldern leisten können. Die Nitratinventur Bayern (MELLERT et al. 2005a, 2005b), bei der auch die Bodenvegetation aufgenommen wurde, bot die Möglichkeit, das Indikatorpotential der Bodenvegetation als Zeiger für Nitratausträge zu prüfen. Die Analyse bietet überdies Ansatzpunkte, zwischen einem durch das Standortpotential bedingten Risiko und dem durch N-Depositionen als anthropogene Ursache für Nitratausträge zu unterscheiden. Zudem wurde geprüft, ob das zur Regionalisierung eingesetzte logistische Regressionsmodell (MELLERT et al. 2005c) durch die Hinzunahme der N-Zeigerwerte verbessert werden kann. Wegen der zu erwartenden Korrelation der Zeigerwerte mit den im Modell verwendeten Standortsindikatoren erhob sich insbesondere die Frage, ob der Zeigerwert die im Modell benutzten Prädiktoren lediglich (z.T.) ersetzt oder ob er die Prognosemöglichkeiten verbessert. Eine wirkliche Verbesserung der Vorhersage ist dann gegeben, wenn der N-Zeigerwert als zusätzlicher Prädiktor ins Modell aufgenommen werden kann und sich die unerklärte Varianz hierdurch signifikant verringert. Von praktischer Bedeutung könnten auch Korrelationen innerhalb der durch die Haupteffekte (Faktoren Wald- und Substrattyp) festgelegten Straten sein.The data of the nitrate inventory in Bavaria allowed to examine whether nitrate leaching of forest soils can be predicted by Ellenberg indicator values. Significant correlation between nitrate concentrations in the top- and the subsoil stressed the indicator potential of the ground vegetation. Significant relationships with modelled ammonium deposition and other deposition indicators reveal the causes of eutrophication of forests in the perspective of the ground vegetation. These relationships point once more to the agriculture as the most important source of nitrogen deposition in forests. Despite, the demonstrated indicator potential the explanation of the analysed regionalisation model could not be improved much by the inclusion of indicator value for nitrogen. Moreover, the limited basis of appropriate geodata hinders the use of ground vegetation within spatial modelling. Nevertheless, the observation of ground vegetation within the biogeochemical monitoring of forests is an important complementary tool. Comprehensive analyses of such approaches should be intensified. This would help to improve the understanding of consequences and dynamics within the process of nitrogen saturation

Double-stack unit train container service: its commercial impact and value to the military skipper

Double-stack container train service was successfully introduced in 1984 and has expanded rapidly since. The newly designed five-platform articulated well railroad car serves as the vehicle. Space-age computer-assisted design has helped to engineer a radical departure fi-om conventional railcar configuration and produce significant weight and rolling resistance reductions. Commensurate with introduction of this new generation of equipment, the ocean carriers and railroads have developed new cooperative train scheduling procedures and container railcar handling methods. Additionally, the higher volume of containers per stack train has forced a redesign of railyards and marine terminals. Opportunities for unique military application of stack train technology and possible container rate reductions await the military transporter. The expedient maturation of stack train technology has provided an early opportunity for a thorough review of its development, the impact upon the containerized freight industry, and the stack trains' potential value to the military.http://archive.org/details/doublestackunitt00bernLieutenant Commander, Supply Corps. United States NavyApproved for public release; distribution is unlimited

Zur Erforschung der polaren troposphärischen Grundschicht vor dem Zweiten Internationalen Polarjahr 1932/1933

In the period between the two polar years 1882/83 and 1932/33, the classical captive and sounding balloon ascent methods developed at aerological observatories were also employed in the polar regions. It was only in the period leading up to the second Polar Year that radiosonde ascents and aircraft sounding came into use as new methods of aerological research. In the North Polar region, vertical temperature, humidity and wind profiles in the boundary layer were developed overseas (Arthur Berson, Hermann Elias, Hugo Hergesell) and in Greenland (Max Robitzsch, Alfred Wegener and others) during the early decades of the twentieth century with the aid of kite, captive and sounding balloon ascents. Here special attention was paid to cloud and inversion layers as well as to the catabatic wind then described for the first time. Various types of boundary layers, among them the extreme stratification conditions during the polar night, were also found by George Clarke Simpson and Erich Barkow in the Antarctic. Barkow’s micrometeorological measurements, including the registration of turbulent temperature fluctuations, are worthy of particular mention

Melting, bubble-like expansion and explosion of superheated plasmonic nanoparticles

We report on time-resolved coherent diffraction imaging of gas-phase silver nanoparticles, strongly heated via their plasmon resonance. The x-ray diffraction images reveal a broad range of phenomena for different excitation strengths, from simple melting over strong cavitation to explosive disintegration. Molecular dynamics simulations fully reproduce this behavior and show that the heating induces rather similar trajectories through the phase diagram in all cases, with the very different outcomes being due only to whether and where the stability limit of the metastable superheated liquid is crossed.Comment: 17 pages, 8 figures (including supplemental material

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)

Large expert-curated database for benchmarking document similarity detection in biomedical literature search

Document recommendation systems for locating relevant literature have mostly relied on methods developed a decade ago. This is largely due to the lack of a large offline gold-standard benchmark of relevant documents that cover a variety of research fields such that newly developed literature search techniques can be compared, improved and translated into practice. To overcome this bottleneck, we have established the RElevant LIterature SearcH consortium consisting of more than 1500 scientists from 84 countries, who have collectively annotated the relevance of over 180 000 PubMed-listed articles with regard to their respective seed (input) article/s. The majority of annotations were contributed by highly experienced, original authors of the seed articles. The collected data cover 76% of all unique PubMed Medical Subject Headings descriptors. No systematic biases were observed across different experience levels, research fields or time spent on annotations. More importantly, annotations of the same document pairs contributed by different scientists were highly concordant. We further show that the three representative baseline methods used to generate recommended articles for evaluation (Okapi Best Matching 25, Term Frequency-Inverse Document Frequency and PubMed Related Articles) had similar overall performances. Additionally, we found that these methods each tend to produce distinct collections of recommended articles, suggesting that a hybrid method may be required to completely capture all relevant articles. The established database server located at https://relishdb.ict.griffith.edu.au is freely available for the downloading of annotation data and the blind testing of new methods. We expect that this benchmark will be useful for stimulating the development of new powerful techniques for title and title/abstract-based search engines for relevant articles in biomedical research.Peer reviewe

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.

OBJECTIVES: To provide an accurate, web-based tool for stratifying patients with atrial fibrillation to facilitate decisions on the potential benefits/risks of anticoagulation, based on mortality, stroke and bleeding risks. DESIGN: The new tool was developed, using stepwise regression, for all and then applied to lower risk patients. C-statistics were compared with CHA2DS2-VASc using 30-fold cross-validation to control for overfitting. External validation was undertaken in an independent dataset, Outcome Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). PARTICIPANTS: Data from 39 898 patients enrolled in the prospective GARFIELD-AF registry provided the basis for deriving and validating an integrated risk tool to predict stroke risk, mortality and bleeding risk. RESULTS: The discriminatory value of the GARFIELD-AF risk model was superior to CHA2DS2-VASc for patients with or without anticoagulation. C-statistics (95% CI) for all-cause mortality, ischaemic stroke/systemic embolism and haemorrhagic stroke/major bleeding (treated patients) were: 0.77 (0.76 to 0.78), 0.69 (0.67 to 0.71) and 0.66 (0.62 to 0.69), respectively, for the GARFIELD-AF risk models, and 0.66 (0.64-0.67), 0.64 (0.61-0.66) and 0.64 (0.61-0.68), respectively, for CHA2DS2-VASc (or HAS-BLED for bleeding). In very low to low risk patients (CHA2DS2-VASc 0 or 1 (men) and 1 or 2 (women)), the CHA2DS2-VASc and HAS-BLED (for bleeding) scores offered weak discriminatory value for mortality, stroke/systemic embolism and major bleeding. C-statistics for the GARFIELD-AF risk tool were 0.69 (0.64 to 0.75), 0.65 (0.56 to 0.73) and 0.60 (0.47 to 0.73) for each end point, respectively, versus 0.50 (0.45 to 0.55), 0.59 (0.50 to 0.67) and 0.55 (0.53 to 0.56) for CHA2DS2-VASc (or HAS-BLED for bleeding). Upon validation in the ORBIT-AF population, C-statistics showed that the GARFIELD-AF risk tool was effective for predicting 1-year all-cause mortality using the full and simplified model for all-cause mortality: C-statistics 0.75 (0.73 to 0.77) and 0.75 (0.73 to 0.77), respectively, and for predicting for any stroke or systemic embolism over 1 year, C-statistics 0.68 (0.62 to 0.74). CONCLUSIONS: Performance of the GARFIELD-AF risk tool was superior to CHA2DS2-VASc in predicting stroke and mortality and superior to HAS-BLED for bleeding, overall and in lower risk patients. The GARFIELD-AF tool has the potential for incorporation in routine electronic systems, and for the first time, permits simultaneous evaluation of ischaemic stroke, mortality and bleeding risks. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier for GARFIELD-AF (NCT01090362) and for ORBIT-AF (NCT01165710)

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.

AIMS: The relationship between outcomes and time after diagnosis for patients with non-valvular atrial fibrillation (NVAF) is poorly defined, especially beyond the first year. METHODS AND RESULTS: GARFIELD-AF is an ongoing, global observational study of adults with newly diagnosed NVAF. Two-year outcomes of 17 162 patients prospectively enrolled in GARFIELD-AF were analysed in light of baseline characteristics, risk profiles for stroke/systemic embolism (SE), and antithrombotic therapy. The mean (standard deviation) age was 69.8 (11.4) years, 43.8% were women, and the mean CHA2DS2-VASc score was 3.3 (1.6); 60.8% of patients were prescribed anticoagulant therapy with/without antiplatelet (AP) therapy, 27.4% AP monotherapy, and 11.8% no antithrombotic therapy. At 2-year follow-up, all-cause mortality, stroke/SE, and major bleeding had occurred at a rate (95% confidence interval) of 3.83 (3.62; 4.05), 1.25 (1.13; 1.38), and 0.70 (0.62; 0.81) per 100 person-years, respectively. Rates for all three major events were highest during the first 4 months. Congestive heart failure, acute coronary syndromes, sudden/unwitnessed death, malignancy, respiratory failure, and infection/sepsis accounted for 65% of all known causes of death and strokes for <10%. Anticoagulant treatment was associated with a 35% lower risk of death. CONCLUSION: The most frequent of the three major outcome measures was death, whose most common causes are not known to be significantly influenced by anticoagulation. This suggests that a more comprehensive approach to the management of NVAF may be needed to improve outcome. This could include, in addition to anticoagulation, interventions targeting modifiable, cause-specific risk factors for death. CLINICAL TRIAL REGISTRATION: http://www.clinicaltrials.gov. Unique identifier: NCT01090362